OCX - Oncocyte Corporation
Previous close
3.1427
0 0%
Share volume: 8,688
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.14
0.00
0.00%
Summary score
9%
Profitability
0%
Dept financing
15%
Liquidity
38%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-27.66%
Return on assets
-7.69%
Return on sales
-1579.74%
Return on invested capital
-17.96%
Total debt ratio
48.57%
Debt ratio change over timeo
-3.57%
Current Ratio
2.46%
Quick Ratio
2.45%
Cash Position Ratio
2.21%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-37.94%
Return on assets
-7.14%
Return on sales
-1870.08%
Return on invested capital
-17.89%
Total debt ratio
58.68%
Debt ratio change over timeo
-4.27%
Current Ratio
1.78%
Quick Ratio
1.78%
Cash Position Ratio
1.52%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-53.95%
Return on assets
-8.15%
Return on sales
-3287.5%
Return on invested capital
-16.27%
Total debt ratio
76.16%
Debt ratio change over time
-3.64%
Current Ratio
0.78%
Quick Ratio
0.78%
Cash Position Ratio
0.67%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-88.96%
Return on assets
-17.21%
Return on sales
9187.17%
Return on invested capital
-85.75%
Total debt ratio
-356.96%
Debt ratio change over time
-3.57%
Current Ratio
-16.27%
Quick Ratio
-16.49%
Cash Position Ratio
-15.07%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | OCX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -27.66% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.69% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1579.74% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -17.96% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 48.57% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -3.57% | 308.97% | -6.99% | 1.18% |
| Dept financing | 13% | 50% | 25% | 7% |
| Current Ratio | 1.78% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.78% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.52% | 0.36% | 1.28% | 2.93% |
| Liquididy | 55% | 14% | 32% | 73% |
| Short-term ratios | OCX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -37.94% | 13.77% | 13.25% | 3.8% |
| Return on assets | -7.14% | 2.43% | 1.89% | 3.09% |
| Return on sales | -1870.08% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -17.89% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 58.68% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -4.27% | 46.38% | -72.08% | 1.51% |
| Dept financing | 16% | 50% | 25% | 7% |
| Current Ratio | 1.78% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.78% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.52% | 0.36% | 1.28% | 2.93% |
| Liquididy | 31% | 12% | 31% | 75% |